Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BEPACT Lung: Impact of Patient Characteristics on Pneumo-oncologists Non Small Cell Lung Cancer (NSCLC) Systemic Treatment Decision in Belgium: A Cross-sectional Study

NCT03959137 is registered in ClinicalTrials.gov with MSD Belgium BVBA as lead sponsor.

NCT NCT03959137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03959137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BEPACT Lung: Impact of Patient Characteristics on Pneumo-oncologists Non Small Cell Lung Cancer (NSCLC) Systemic Treatment Decision in Belgium: A Cross-sectional Study
Lead sponsor
MSD Belgium BVBA
Phase
Observational
Overall status
Completed
Start date
June 3, 2019
Completion date
October 31, 2019
Enrollment
215 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

stage iv non-small cell lung cancer